Andrea Galbiati

12PUBLICATIONS
40CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesPharmaceutical delivery technologiesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 16, 2026
A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors.

|Feb 13, 2026
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Matilde Bocci, Laura Lucaroni, Domenico Ravazza

|Jun 30, 2025
Development of Multivalent FAP-Targeted Small Molecule-Drug Conjugates with Tailored MMAE Release Kinetics.

Matilde Bocci, Lucrezia Principi, Dario Neri

|Mar 04, 2025
PSMA-Targeted Small Molecule-Drug Conjugates Based on a Postprolyl Peptidase-Cleavable Linker for the Treatment of Prostate Cancer.

Tony Georgiev, Sara Puglioli, Lucrezia Principi

|Dec 24, 2024
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule-Drug Conjugates Elicits Potent In Vivo Anticancer Activity.

Matilde Bocci, Lucrezia Principi, Ettore Gilardoni

|Nov 11, 2024
Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics.

Andrea Galbiati, Matilde Bocci, Dario Neri

Pageof 2

Frequent Collaborators

7 joint publications

Ettore Gilardoni

7 joint publications

Samuele Cazzamalli

6 joint publications

Matilde Bocci

4 joint publications

Aureliano Zana